Clinical outcomes in the total and propensity score-matched populations.

<p>Clinical outcomes in the total and propensity score-matched populations.</p

Detailed description of definite or probable stent thrombosis.

<p>Detailed description of definite or probable stent thrombosis.</p

Kaplan-Meier curves for clinical outcomes in the propensity score-matched cohort.

<p>(A) Target lesion failure. (B) Target lesion failure at 1-year landmark. There were no significant differences of clinical outcomes between 2 groups. BP-BES = biodegradable polymer biolimus-eluting stent; DP-EES = durable polymer everolimus-eluting stent.</p

Kaplan-Meier curves for definite or probable stent thrombosis.

<p>BP-BES = biodegradable polymer biolimus-eluting stent; DAPT = dual antiplatelet therapy; DP-EES = durable polymer everolimus-eluting stent.</p

Study population.

<p>BP-BES = biodegradable polymer biolimus-eluting stent; DP-EES = durable polymer everolimus-eluting stent.</p

Stent thrombosis and use of dual antiplatelet therapy in the total and propensity score-matched populations.

<p>Stent thrombosis and use of dual antiplatelet therapy in the total and propensity score-matched populations.</p